Do patients with heart failure benefit from coronary artery bypass grafting?

Edwin C. Mcgee*, Patrick M. Mccarthy

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

PURPOSE OF REVIEW: The purpose of this review is to examine the appropriateness of coronary artery bypass grafting (CABG) for the patient with ischemic cardiomyopathy and congestive heart failure. RECENT FINDINGS: CABG is the gold standard therapy for patients with advanced multivessel and left main coronary artery disease. A critical analysis of the Surgical Treatment of Ischemic Heart Failure (STICH) trial confirms the benefit of CABG for patients with ischemic cardiomyopathy. SUMMARY: CABG can be safely applied to patients with heart failure and provides benefit for appropriately selected patients.

Original languageEnglish (US)
Pages (from-to)629-633
Number of pages5
JournalCurrent opinion in cardiology
Volume27
Issue number6
DOIs
StatePublished - Nov 1 2012

Keywords

  • Surgical Treatment of Ischemic Heart Failure (STICH) trial
  • heart failure
  • ischemic cardiomyopathy
  • myocardial viability

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Do patients with heart failure benefit from coronary artery bypass grafting?'. Together they form a unique fingerprint.

Cite this